Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

343 ARTÍCULOS , VIENDO DEL 1 AL 15

Facilitating the use of implicit memory and learning in the physical therapy management of individuals with Alzheimer disease: a case series

White L, Ford MP, Brown CJ, Peel C, Triebel KL.

J Geriatr Phys Ther. 2014 Jan-Mar;37(1):35-44. doi: 10.1519/JPT.0b013e3182862d2c.

Curcumin and curcumin-like molecules: from spice to drugs

Marchiani A, Rozzo C, Fadda A, Delogu G, Ruzza P.

Curr Med Chem. 2014;21(2):204-22. doi: 10.2174/092986732102131206115810.

Disruption of zinc neuromodulation by Aß oligomers: therapeutic implications

Vogler EC, Busciglio J.

Curr Pharm Des. 2014;20(15):2520-4. doi: 10.2174/13816128113199990510.

Hippocampal neurogenesis in Alzheimer's disease: is there a role for dietary modulation?

Maruszak A, Pilarski A, Murphy T, Branch N, Thuret S.

J Alzheimers Dis. 2014;38(1):11-38. doi: 10.3233/JAD-131004.

Cellular prion protein as a therapeutic target in Alzheimer's disease

Laurén J.

J Alzheimers Dis. 2014;38(2):227-44. doi: 10.3233/JAD-130950.

Targeting synaptic dysfunction in Alzheimer's disease by administering a specific nutrient combination

van Wijk N, Broersen LM, de Wilde MC, Hageman RJ, Groenendijk M, Sijben JW, Kamphuis PJ.

J Alzheimers Dis. 2014;38(3):459-79. doi: 10.3233/JAD-130998.

Current view from Alzheimer disease to type 2 diabetes mellitus

Rasool M, Malik A, Qazi AM, Sheikh IA, Manan A, Shaheen S, Qazi MH, Chaudhary AG, Abuzenadah AM, Asif M, Alqahtani MH, Iqbal Z, Shaik MM, Gan SH, Kamal MA.

CNS Neurol Disord Drug Targets. 2014 Apr;13(3):533-42. doi: 10.2174/18715273113126660167.

A nanotechnological approach to the management of Alzheimer disease and type 2 diabetes

Alam Q, ZubairAlam M, Karim S, Gan SH, Kamal MA, Jiman-Fatani A, Damanhouri GA, Abuzenadah AM, Chaudhary AG, Haque A.

CNS Neurol Disord Drug Targets. 2014 Apr;13(3):478-86. doi: 10.2174/18715273113126660159.

Bacteriophage--a common divergent therapeutic approach for Alzheimer's disease and type II diabetes mellitus

Sohrab SS, Karim S, Kamal MA, Abuzenadah AM, Chaudhary AG, Al-Qahtani MH, Mirza Z.

CNS Neurol Disord Drug Targets. 2014 Apr;13(3):491-500. doi: 10.2174/18715273113126660158.

Alzheimer's and type 2 diabetes treatment via common enzyme targeting

Jabir NR, Kamal MA, Abuzenadah AM, Gan SH, Alama MN, Baeesa SS, Tabrez S.

CNS Neurol Disord Drug Targets. 2014 Mar;13(2):299-304. doi: 10.2174/18715273113126660145.

The role of neuronal insulin/insulin-like growth factor-1 signaling for the pathogenesis of Alzheimer's disease: possible therapeutic implications

Zemva J, Schubert M.

CNS Neurol Disord Drug Targets. 2014 Mar;13(2):322-37. doi: 10.2174/18715273113126660141.

Fighting Alzheimer's disease and type 2 diabetes: pathological links and treatment strategies

Dai Y, Kamal MA.

CNS Neurol Disord Drug Targets. 2014 Mar;13(2):271-82. doi: 10.2174/18715273113126660134.

Anesthetics and its impact on the brain and Alzheimer's disease

Mandal PK, Ritchie K, Fodale V.

J Alzheimers Dis. 2014;39(2):223-5. doi: 10.3233/JAD-131487.

The effects of different antioxidants on the activity of cerebrocortical MnSOD and Na,K-ATPase from post mortem Alzheimer's disease and age-matched normal brains

Kairane C, Mahlapuu R, Ehrlich K, Zilmer M, Soomets U.

Curr Alzheimer Res. 2014 Jan;11(1):79-85. doi: 10.2174/15672050113106660179.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias